Skip to main content
OpenTrials

Clinical trial condition

Recurrent Breast Cancer

Explore clinical trials studying Recurrent Breast Cancer. Study availability and eligibility vary by location and protocol.

99 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Breast Cancer trial results

Completed

Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer

NCT01730833

Conditions
Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • City of Hope- South Pasadena Cancer Center South Pasadena, California, United States
View Trial Details
Completed

ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer

NCT06570031

Conditions
Breast Diseases, Breast Neoplasms, Disease Attributes, +13 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Chiba Cancer Center Chiba, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
View all 13 locations
View Trial Details
Completed

Circulating miRNAs.

NCT01722851

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +10 more
Locations
  • Bon Secours Hospital Cork, Ireland
  • Beaumont Hospital Dublin, Ireland
  • St James's Hospital Dublin, Ireland
  • University Hospital Galway Galway, Ireland
View Trial Details
Completed

T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer

NCT03530696

Conditions
Breast Cancer, Breast Cancer Stage, Breast Diseases, +9 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Cedar-Sinai Beverly Hills, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 16 locations
View Trial Details
Completed

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

NCT00577122

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, San Francisco Comprehensive Cancer Center San Francisco, California, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions